Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance

被引:21
|
作者
Imai, Y [1 ]
Sasaki, T [1 ]
Shinagawa, Y [1 ]
Akimoto, K [1 ]
Fujibayashi, T [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Oral & Maxillofacial Surg, Mibu, Tochigi 3210293, Japan
来源
ORAL ONCOLOGY | 2002年 / 38卷 / 06期
关键词
oral squamous cell carcinoma; metastasis suppressor gene (KAI1/CD82); prognostic factor;
D O I
10.1016/S1368-8375(01)00120-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we investigated the expression of the KAI1/CD82 gene in oral squamous cell carcinoma (oral SCC). We Studied 43 oral SCC patients. Reverse transcription-polymerase chain reaction (RT-PCR) analysis was performed to evaluate expression of this gene, and results were compared to the clinico-pathological findings. Twenty-five specimens (58.1%) were KAI1/CD82-positive, and 18 (41.9%) were negative. There were statistically significant relationships between gene expression and both histological malignancy (P=0.0205) and mode of invasion (P=0.0315). But there were no correlations of expression with tumor status, regional lymph node metastasis, pathological lymph node metastasis or histological differentiation. No significant relationship was observed between patient survival and expression of KAI1/CD82 by tumors. The results of this study suggest that the KAI1/CD82 gene may not be a useful predictor of prognosis, although decreased gene expression may be associated with increased invasive ability of oral SCC. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:557 / 561
页数:5
相关论文
共 50 条
  • [1] KAI1/CD82, a tumor metastasis suppressor
    Liu, Wei M.
    Zhang, Xin A.
    CANCER LETTERS, 2006, 240 (02) : 183 - 194
  • [2] Expression of KAI1/CD82 and CD44v6 in laryngeal squamous cell carcinoma and its significance
    Sun, Jian-Song
    Zhou, Ming-Qi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9113 - 9125
  • [3] Dissecting the diverse functions of the metastasis suppressor CD82/KAI1
    Tsai, Yien Che
    Weissman, Allan M.
    FEBS LETTERS, 2011, 585 (20): : 3166 - 3173
  • [4] Role of Metastasis Suppressor KAI1/CD82 in Different Cancers
    Yan, Wei
    Huang, Jinny
    Zhang, Qian
    Zhang, Jian
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [5] Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma
    Wang, Gengming
    Jiang, Hao
    Xu, Hongbo
    Sun, Qian
    Zhou, Yan
    Xiang, Ping
    Cheng, Zenong
    Zhang, Yajun
    Zhou, Yufu
    Guo, Qing
    Du, Xinglong
    Xu, Shuxiu
    Ma, Shiyin
    Chen, Zhendong
    ONCOLOGY LETTERS, 2015, 9 (04) : 1681 - 1686
  • [6] KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma
    Prabhu, V. Vinod
    Devaraj, S. Niranjali
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2017, 36 (03) : 269 - 275
  • [7] Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1
    Ordas, Laura
    Costa, Luca
    Lozano, Anthony
    Chevillard, Christopher
    Calovoulos, Alexia
    Kantar, Diala
    Fernandez, Laurent
    Chauvin, Lucie
    Dosset, Patrice
    Doucet, Christine
    Heron-Milhavet, Lisa
    Odintsova, Elena
    Berditchevski, Fedor
    Milhiet, Pierre-Emmanuel
    Benistant, Christine
    CELLS, 2021, 10 (06)
  • [8] Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines
    Kim, Young Il
    Shin, Min-Kyung
    Lee, Jin-Woo
    Chung, Joo-Ho
    Lee, Mu-Hyoung
    ONCOLOGY REPORTS, 2009, 21 (01) : 159 - 164
  • [9] Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma
    Miyazaki, T
    Kato, H
    Shitara, Y
    Yoshikawa, M
    Tajima, K
    Masuda, N
    Shouji, H
    Tsukada, K
    Nakajima, T
    Kuwano, H
    CANCER, 2000, 89 (05) : 955 - 962
  • [10] CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1
    Zeng, T. -D.
    Zheng, B.
    Zheng, W.
    Chen, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (18) : 5928 - 5937